Starton Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 7

Employees

  • Latest Deal Type
  • IPO
  • (Announced)

  • Latest Deal Amount
  • $30M

  • Investors
  • 4

Starton Therapeutics General Information

Description

Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Contact Information

Formerly Known As
ChemioCare, 2022168 Alberta
Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Corporate Office
  • 215 College Road
  • Suite 300
  • Paramus, NJ 07652
  • United States
+1 (800)
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Corporate Office
  • 215 College Road
  • Suite 300
  • Paramus, NJ 07652
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Starton Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. IPO 11-Dec-2025 $30M Announced Generating Revenue/Not Profitable
8. Reverse Merger 03-Nov-2023 Cancelled Clinical Trials - Phase 2
7. Later Stage VC 11-Oct-2023 Completed Clinical Trials - Phase 2
6. Later Stage VC 01-Jun-2022 Completed Clinical Trials - Phase 2
5. Later Stage VC 16-Feb-2022 Completed Clinical Trials - Phase 2
4. Early Stage VC 19-Nov-2021 Completed Clinical Trials - Phase 2
3. Early Stage VC 26-May-2021 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 13-Jan-2020 $2.04M $15.7M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 18-Jul-2018 $13.7M $13.7M Completed Clinical Trials - Phase 2
To view Starton Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Starton Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with propriet
Drug Discovery
Paramus, NJ
7 As of 2026

Cary, NC
 

Galashiels, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Starton Therapeutics Competitors (3)

One of Starton Therapeutics’s 3 competitors is Heron Therapeutics, a Formerly VC-backed company based in Cary, NC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Heron Therapeutics Formerly VC-backed Cary, NC
Kyowa Kirin International Formerly PE-Backed Galashiels, United Kingdom
Helsinn Healthcare Corporation Lugano, Switzerland
You’re viewing 3 of 3 competitors. Get the full list »

Starton Therapeutics Patents

Starton Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260224497-A1 Controlled release delivery of low water solubility compounds via oral administration Pending 31-Jan-2025
WO-2026164922-A1 Controlled release delivery of low water solubility compounds via oral administration Pending 31-Jan-2025
WO-2026151833-A1 Non-aqueous stable solutions for subcutaneous drug delivery Pending 09-Jan-2025
AU-2025206255-A1 Solid state active pharmaceutical compositions for transdermal drug delivery Pending 05-Jan-2024
EP-4836802-A1 Solid state active pharmaceutical compositions for transdermal drug delivery Pending 05-Jan-2024 A61K9/7061
To view Starton Therapeutics’s complete patent history, request access »

Starton Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Starton Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endeavor Capital Management Venture Capital Minority
Jolt Health Corporation Minority
Accent Capital Venture Capital Minority
MBX Capital Venture Capital Minority
To view Starton Therapeutics’s complete investors history, request access »

Starton Therapeutics FAQs

  • When was Starton Therapeutics founded?

    Starton Therapeutics was founded in 2017.

  • Where is Starton Therapeutics headquartered?

    Starton Therapeutics is headquartered in Paramus, NJ.

  • What is the size of Starton Therapeutics?

    Starton Therapeutics has 7 total employees.

  • What industry is Starton Therapeutics in?

    Starton Therapeutics’s primary industry is Drug Discovery.

  • Is Starton Therapeutics a private or public company?

    Starton Therapeutics is a Private company.

  • What is the current valuation of Starton Therapeutics?

    The current valuation of Starton Therapeutics is .

  • What is Starton Therapeutics’s current revenue?

    The current revenue for Starton Therapeutics is .

  • How much funding has Starton Therapeutics raised over time?

    Starton Therapeutics has raised $57M.

  • Who are Starton Therapeutics’s investors?

    Endeavor Capital Management, Jolt Health, Accent Capital, and MBX Capital have invested in Starton Therapeutics.

  • Who are Starton Therapeutics’s competitors?

    Heron Therapeutics, Kyowa Kirin International, and Helsinn Healthcare are competitors of Starton Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process